Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
European Urology
|
June 12, 1999
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics
M Graefen, J Noldus, U Pichlmeier, et al.
Der Urologe. Ausg. A
|
February 9, 2000
[Prognostic markers for prostate cancer]
M Graefen, P Hammerer, J Noldus, et al.
International Journal of Clinical Practice
|
May 27, 2004
Management of prostate-specific antigen relapse in prostate cancer: a European Consensus
L Boccon-Gibod, W B Djavan, P Hammerer, et al.
Aktuelle Urologie
|
July 27, 2013
[Value of intermittent androgen deprivation in the context of the current data situation]
K Miller, P Hammerer, R Eichenauer, et al.
Der Urologe. Ausg. A
|
May 2, 2019
[Treatment situation in metastastic Castration Naive Prostate Cancer (mCRPC) and the implications on clinical routine]
C Wülfing, M Bögemann, P J Goebell, et al.
Der Urologe. Ausg. A
|
June 26, 2019
C Wülfing, M Bögemann, P J Goebell, et al.
Der Urologe. Ausg. A
|
May 30, 2018
[Advanced Prostate Cancer Consensus Conference 2017 : Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts]
M Schostak, F König, M Bögemann, et al.
The Prostate
|
May 8, 2001
A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis
M Lein, K Jung, P Hammerer, et al.
Der Urologe. Ausg. A
|
December 26, 2015
[Prostate biopsy: Procedure in the clinical routine]
T Enzmann, T Tokas, K Korte, et al.
World Journal of Urology
|
March 3, 2018
Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patients
Jonas Schiffmann, Pierre I Karakiewicz, Michael Rink, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
European Urology
|
June 12, 1999
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics
M Graefen, J Noldus, U Pichlmeier, et al.
Der Urologe. Ausg. A
|
February 9, 2000
[Prognostic markers for prostate cancer]
M Graefen, P Hammerer, J Noldus, et al.
International Journal of Clinical Practice
|
May 27, 2004
Management of prostate-specific antigen relapse in prostate cancer: a European Consensus
L Boccon-Gibod, W B Djavan, P Hammerer, et al.
Aktuelle Urologie
|
July 27, 2013
[Value of intermittent androgen deprivation in the context of the current data situation]
K Miller, P Hammerer, R Eichenauer, et al.
Der Urologe. Ausg. A
|
May 2, 2019
[Treatment situation in metastastic Castration Naive Prostate Cancer (mCRPC) and the implications on clinical routine]
C Wülfing, M Bögemann, P J Goebell, et al.
Der Urologe. Ausg. A
|
June 26, 2019
C Wülfing, M Bögemann, P J Goebell, et al.
Der Urologe. Ausg. A
|
May 30, 2018
[Advanced Prostate Cancer Consensus Conference 2017 : Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts]
M Schostak, F König, M Bögemann, et al.
The Prostate
|
May 8, 2001
A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis
M Lein, K Jung, P Hammerer, et al.
Der Urologe. Ausg. A
|
December 26, 2015
[Prostate biopsy: Procedure in the clinical routine]
T Enzmann, T Tokas, K Korte, et al.
World Journal of Urology
|
March 3, 2018
Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patients
Jonas Schiffmann, Pierre I Karakiewicz, Michael Rink, et al.
Page
of 9